[{"id":"71bc2a0d-5c54-4fba-a0e8-7b6c12ec8266","acronym":"","url":"https://clinicaltrials.gov/study/NCT02718144","created_at":"2021-01-18T13:17:46.362Z","updated_at":"2024-07-02T16:36:28.879Z","phase":"Phase 1/2","brief_title":"Assessment of Safety and Efficacy of Estetrol in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer","source_id_and_acronym":"NCT02718144","lead_sponsor":"Pantarhei Oncology B.V.","biomarkers":" HER-2 • ER","pipe":" | ","alterations":" ER positive • HER-2 negative • ER positive + HER-2 negative","tags":["HER-2 • ER"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ER positive • HER-2 negative • ER positive + HER-2 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Donesta (estetrol)"],"overall_status":"Completed","enrollment":" Enrollment 12","initiation":"Initiation: 06/01/2017","start_date":" 06/01/2017","primary_txt":" Primary completion: 12/31/2019","primary_completion_date":" 12/31/2019","study_txt":" Completion: 12/31/2019","study_completion_date":" 12/31/2019","last_update_posted":"2021-06-18"}]